Summary of proliferative responses to RhD protein and RhD peptides by patients with CLL without overt AIHA (CLL)
Patient . | Purified RhD protein-induced proliferation . | Rh-specific peptides stimulating proliferation* . |
|---|---|---|
| 1 | N | None |
| 2 | Y | 15, 16, 31, 34, 47 |
| 3 | Y | 17, 40 |
| 4 | N | None |
| 5 | Y | 2, 3, 17 |
| 6 | Y | None |
| 7 | Y | 2, 9, 41 |
| 8 | Y | None |
| 9 | Y | 14, 38 |
| 10 | Y | 27, 28, 29, 30, 41, 42, 53, 54, 63, 68 |
Patient . | Purified RhD protein-induced proliferation . | Rh-specific peptides stimulating proliferation* . |
|---|---|---|
| 1 | N | None |
| 2 | Y | 15, 16, 31, 34, 47 |
| 3 | Y | 17, 40 |
| 4 | N | None |
| 5 | Y | 2, 3, 17 |
| 6 | Y | None |
| 7 | Y | 2, 9, 41 |
| 8 | Y | None |
| 9 | Y | 14, 38 |
| 10 | Y | 27, 28, 29, 30, 41, 42, 53, 54, 63, 68 |
PBMCs from patient tested with the panel of synthetic RhD peptides to match phenotype.